The Chinese Pulmonary Lymphoepithelioma-like Carcinoma Collaboration Study

NCT06801977 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-01-30

No results posted yet for this study

Summary

This retrospective case-control study aims to investigate the genetic mechanisms of primary Pulmonary Lymphoepithelioma-like Carcinoma, identify genetic susceptibility loci associated with its onset, and explore potential pathogenic genes, providing new insights for its etiological research.

Conditions

  • Primary Pulmonary Lymphoepithelioma-like Carcinoma

Interventions

GENETIC

Genome-wide genotyping

Whole blood from the participants was used to extract DNA for genotyping.

Sponsors & Collaborators

  • First People's Hospital of Foshan

    collaborator OTHER
  • Sun Yat-sen University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-01-01
Primary Completion
2025-06-30
Completion
2030-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06801977 on ClinicalTrials.gov